JP2024523003A5 - - Google Patents

Info

Publication number
JP2024523003A5
JP2024523003A5 JP2023574779A JP2023574779A JP2024523003A5 JP 2024523003 A5 JP2024523003 A5 JP 2024523003A5 JP 2023574779 A JP2023574779 A JP 2023574779A JP 2023574779 A JP2023574779 A JP 2023574779A JP 2024523003 A5 JP2024523003 A5 JP 2024523003A5
Authority
JP
Japan
Prior art keywords
dll3
domain
trispecific protein
ligand
delta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023574779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024523003A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/031919 external-priority patent/WO2022256500A2/en
Publication of JP2024523003A publication Critical patent/JP2024523003A/ja
Publication of JP2024523003A5 publication Critical patent/JP2024523003A5/ja
Pending legal-status Critical Current

Links

JP2023574779A 2021-06-03 2022-06-02 Dll3標的化三重特異性タンパク質およびそれらの使用方法 Pending JP2024523003A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163196619P 2021-06-03 2021-06-03
US63/196,619 2021-06-03
US202163288939P 2021-12-13 2021-12-13
US63/288,939 2021-12-13
US202263345150P 2022-05-24 2022-05-24
US63/345,150 2022-05-24
PCT/US2022/031919 WO2022256500A2 (en) 2021-06-03 2022-06-02 Dll3 targeting trispecific proteins and methods of use

Publications (2)

Publication Number Publication Date
JP2024523003A JP2024523003A (ja) 2024-06-25
JP2024523003A5 true JP2024523003A5 (cg-RX-API-DMAC7.html) 2025-06-10

Family

ID=84323573

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023574779A Pending JP2024523003A (ja) 2021-06-03 2022-06-02 Dll3標的化三重特異性タンパク質およびそれらの使用方法

Country Status (6)

Country Link
US (1) US20240218063A1 (cg-RX-API-DMAC7.html)
EP (1) EP4347637A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024523003A (cg-RX-API-DMAC7.html)
AU (1) AU2022286407A1 (cg-RX-API-DMAC7.html)
CA (1) CA3220884A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022256500A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3297672B1 (en) 2015-05-21 2021-09-01 Harpoon Therapeutics, Inc. Trispecific binding proteins and methods of use
KR102530742B1 (ko) 2016-05-20 2023-05-09 하푼 테라퓨틱스, 인크. 단일 도메인 혈청 알부민 결합 단백질
IL315737A (en) 2017-10-13 2024-11-01 Harpoon Therapeutics Inc B-cell maturation antigen-binding proteins
CA3078969A1 (en) 2017-10-13 2019-04-18 Harpoon Therapeutics, Inc. Trispecific proteins and methods of use
US12195544B2 (en) 2018-09-21 2025-01-14 Harpoon Therapeutics, Inc. EGFR binding proteins and methods of use
CN119306844A (zh) 2018-09-25 2025-01-14 哈普恩治疗公司 Dll3结合蛋白及使用方法
WO2024215875A2 (en) * 2023-04-14 2024-10-17 Harpoon Therapeutics, Inc. Compositions and methods for enhancing anti-tumor immunity
CN121620371A (zh) 2023-05-19 2026-03-06 勃林格殷格翰国际公司 T细胞衔接蛋白在治疗癌症中的用途
CN122421983A (zh) * 2023-10-19 2026-07-17 哈珀恩治疗公司 Dll3靶向三特异性蛋白及其使用方法
WO2025201493A1 (zh) * 2024-03-29 2025-10-02 诺纳生物(苏州)有限公司 Dll3结合分子及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020012217A (es) * 2018-05-14 2021-03-02 Harpoon Therapeutics Inc Porción de unión para activación condicional de moléculas de inmunoglobulina.
CN119306844A (zh) * 2018-09-25 2025-01-14 哈普恩治疗公司 Dll3结合蛋白及使用方法

Similar Documents

Publication Publication Date Title
JP2024532374A5 (cg-RX-API-DMAC7.html)
JP2020002171A5 (cg-RX-API-DMAC7.html)
JP2012509889A5 (cg-RX-API-DMAC7.html)
JP2013520442A5 (cg-RX-API-DMAC7.html)
JP2022545835A5 (cg-RX-API-DMAC7.html)
JP2021519076A5 (cg-RX-API-DMAC7.html)
JP2014114288A5 (cg-RX-API-DMAC7.html)
JP2013173775A5 (cg-RX-API-DMAC7.html)
JP2017031160A5 (cg-RX-API-DMAC7.html)
JP2004512262A5 (cg-RX-API-DMAC7.html)
JP2019526595A5 (cg-RX-API-DMAC7.html)
JP2023517243A5 (cg-RX-API-DMAC7.html)
JP2006513184A5 (cg-RX-API-DMAC7.html)
JOP20220104A1 (ar) نظام تجريع لعوامل مضادة لـ dll3
JP2021518394A5 (cg-RX-API-DMAC7.html)
JP2017537927A5 (cg-RX-API-DMAC7.html)
JP2024016209A5 (cg-RX-API-DMAC7.html)
JP2021528438A5 (cg-RX-API-DMAC7.html)
JP2022523045A5 (cg-RX-API-DMAC7.html)
JP2022523530A5 (cg-RX-API-DMAC7.html)
JP2019507759A5 (cg-RX-API-DMAC7.html)
JP2024517085A5 (cg-RX-API-DMAC7.html)
JP2019524820A5 (cg-RX-API-DMAC7.html)
JP2023500697A5 (cg-RX-API-DMAC7.html)
JP2020533382A5 (cg-RX-API-DMAC7.html)